We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
26
Chevron
CVX
$371B
$210M 1.58%
2,356,251
+26,661
+1% +$2.39M
AMGN icon
27
Amgen
AMGN
$219B
$209M 1.57%
885,164
+2,635
+0.3% +$601K
ITW icon
28
Illinois Tool Works
ITW
$84.8B
$199M 1.49%
1,135,632
-5,100
-0.4% -$833K
MDT icon
29
Medtronic
MDT
$110B
$197M 1.48%
2,151,286
+21,188
+1% +$2.03M
SRE icon
30
Sempra
SRE
$55.1B
$196M 1.47%
3,344,846
+97,044
+3% +$5.96M
PNC icon
31
PNC Financial Services
PNC
$101B
$195M 1.47%
1,856,036
+67,436
+4% +$7.11M
LLY icon
32
Eli Lilly
LLY
$1.06T
$182M 1.37%
1,109,198
+31,258
+3% +$4.8M
WEC icon
33
WEC Energy
WEC
$35.2B
$165M 1.24%
1,879,940
+24,289
+1% +$2.19M
CMCSA icon
34
Comcast
CMCSA
$89.3B
$152M 1.14%
3,899,574
-157,459
-4% -$6M
USB icon
35
US Bancorp
USB
$99.4B
$150M 1.13%
4,061,797
+39,593
+1% +$1.41M
AAPL icon
36
Apple
AAPL
$4.56T
$146M 1.1%
1,601,224
-239,828
-13% -$18.6M
VZ icon
37
Verizon
VZ
$195B
$140M 1.05%
2,540,499
+468,878
+23% +$26.4M
KO icon
38
Coca-Cola
KO
$374B
$128M 0.96%
2,859,121
+6,075
+0.2% +$280K
BR icon
39
Broadridge
BR
$18.8B
$122M 0.92%
968,471
+3,767
+0.4% +$436K
ACN icon
40
Accenture
ACN
$105B
$108M 0.81%
500,779
+1,332
+0.3% +$252K
PLD icon
41
Prologis
PLD
$130B
$105M 0.79%
1,123,064
+197,054
+21% +$17.6M
ETN icon
42
Eaton
ETN
$174B
$85.5M 0.64%
977,647
+31,171
+3% +$2.57M
CDW icon
43
CDW
CDW
$18.1B
$84.7M 0.64%
728,889
+52,600
+8% +$5.7M
MXIM
44
DELISTED
Maxim Integrated Products
MXIM
$82M 0.62%
1,353,500
+6,540
+0.5% +$364K
PSX icon
45
Phillips 66
PSX
$82.4B
$82M 0.62%
1,140,174
+8,373
+0.7% +$593K
UNH icon
46
UnitedHealth
UNH
$367B
$76.1M 0.57%
257,979
+64,061
+33% +$18.4M
CTAS icon
47
Cintas
CTAS
$80.9B
$68.4M 0.51%
1,027,176
+2,344
+0.2% +$136K
O icon
48
Realty Income
O
$58.2B
$67.3M 0.51%
1,167,734
-385,329
-25% -$20.5M
NOC icon
49
Northrop Grumman
NOC
$80.7B
$66.6M 0.5%
216,726
+5,273
+2% +$1.73M
SYK icon
50
Stryker
SYK
$129B
$62.7M 0.47%
347,975
-994
-0.3% -$183K
1
2
3 4 5

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.